|
Status |
Public on Jul 18, 2017 |
Title |
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer progression |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
28724614 |
|
Submission date |
Jan 19, 2017 |
Last update date |
May 15, 2019 |
Contact name |
Etienne Audet-Walsh |
E-mail(s) |
etienne.audet-walsh@crchudequebec.ulaval.ca
|
Organization name |
Université Laval
|
Department |
Molecular Medicine
|
Street address |
2705 boulevard Laurier
|
City |
Québec City |
State/province |
QC |
ZIP/Postal code |
G1V 4G2 |
Country |
Canada |
|
|
Platforms (2) |
GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
Samples (15)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE93603 |
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer progression [array] |
GSE93845 |
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer progression [ChIP-seq] |
|
Relations |
BioProject |
PRJNA362588 |